Commission Sets Out Its Stall on Anticounterfeiting Measures

Batch pedigrees, obligatory product seals, mass serialization, mandatory audits and tighter requirements for the manufacture, import, export and transportation of medicinal products are among the legislative steps being considered by the European Commission to counter the growing threat of counterfeit drugs in the EU.
in-Pharma Technologist